Sarepta Therapeutics Inc SRPT shares are trading higher by $0.71 (3.8 percent) in Friday's session. The pharmaceutical company whose future is tied to the approval of its main drug, Eteplirsen, had a strange unexplained move in pre-market trading.
Around 6:30 a.m. ET, the issue moved up on only 1600 shares to $23.20 and quickly came down on much bigger volume. One of the two things occurred. Either a trader purposely bid up the shares to instigate some sort of panic buying in the issue, which can move wildly on headlines.
Or, it was the case of a fat-finger. In other words, a trader did not enter the correct price that was near the market and as a result took whatever liquidity was available. For example, if the trader wanted to purchase 1600 shares at $18 and put in $28, it would seek liquidity up to that level.
At this time, the high for the day stands at $18.67, while hitting a low of $17.85.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
